SI
HSTO

Sofinnova Investments’s Histogen Inc. Common Stock HSTO Stock Holding History

Sofinnova Investments’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-750
Closed -$162K – 87
2019
Q1 		$162K Buy
+750
New +$302K 0.02% 67

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sofinnova Investments's HSTO Position: Q1 2019 in Review

Sofinnova Investments sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 3,191 shares — an estimated $1.29M sold.

Sofinnova Investments first reported a position in HSTO in Q2 2018 and held it in 3 quarters. The position peaked at $3.68M in Q2 2018. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • Sofinnova Investments reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sofinnova Investments sold 3,191 Histogen Inc. Common Stock shares in Q1 2019, an estimated $1.29M.
  • Sofinnova Investments first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Sofinnova Investments's Histogen Inc. Common Stock position peaked at $3.68M in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on Sofinnova Investments's 13F filing for Q1 2019, filed 15 May 2019.